Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...

Gilead Sciences, Inc. ("Gilead") (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or v ...

Let’s talk about my PFWA awards ballot, featuring tough decisions at MVP, defensive player of the year and defensive rookie ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

Roland's parents, Steven and Gabrielle Deschain, were pivotal figures that shaped him into the hero of The Dark Tower series.

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ahead.

Eng Grolig stated that they had been providing services in various countries worldwide, although they had not yet expanded ...

Stephen King has a slew of new books coming out in the next few years, but long-teased sequel he finally confirmed is the ...